Last reviewed · How we verify
Poly-L-Lactic Acid
At a glance
| Generic name | Poly-L-Lactic Acid |
|---|---|
| Also known as | Sculptra |
| Sponsor | Bausch Health Americas, Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prospective Clinical Investigation to Evaluate the Safety and Effectiveness of Juläine™ in Improving Gluteal Skin Laxity in Adults. (NA)
- A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients (PHASE1, PHASE2)
- Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars (NA)
- Study on the Efficacy and Safety of PLLA Injections for Improving Facial Laxity Following GLP-1 Analog Therapy (NA)
- Randomized Trial of Combination Treatment With Sofwave and Sculptra (PHASE4)
- A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages (NA)
- To Evaluate the Safety and Efficacy of Poly-L-lactic Acid Implants for the Correction of Nasolabial Folds (NA)
- Safety and Effectiveness of Sculptra 011611 for Improvement in Appearance of Gluteal Skin Irregularities (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Poly-L-Lactic Acid CI brief — competitive landscape report
- Poly-L-Lactic Acid updates RSS · CI watch RSS
- Bausch Health Americas, Inc. portfolio CI